Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB26FQTCY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,389
Award facts
- Contract value 100% obligated
- $1,388.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,388.62 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The award was issued on October 29, 2025, with an ultimate completion date of November 20, 2025, under a firm fixed-price contract structure with no set-aside designation. This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition initiative designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, holding a single-award IDC under the PPV-G GEN V program with a $499.999 billion ceiling value extending through December 31, 2036. The company's product portfolio encompasses a broad range of pharmaceuticals including branded and generic prescription medications, biologics, vaccines, and specialty surgical products, with demonstrated capability to fulfill the diverse medical supply requirements of military healthcare operations globally. This delivery order for contraceptive implants represents one of numerous recent awards issued to the company by the Defense Logistics Agency's Medical Supply Chain division, reflecting consistent contract performance across multiple therapeutic categories.
Quick answers
Who was awarded contract SPE2DB26FQTCY?
SPE2DB26FQTCY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FQTCY worth?
The government has obligated $1,389 on SPE2DB26FQTCY.
Is contract SPE2DB26FQTCY an order under another contract?
Yes. SPE2DB26FQTCY is a delivery order under SPE2DB25D9301, an indefinite delivery contract.
Was contract SPE2DB26FQTCY competed?
The extent of competition for SPE2DB26FQTCY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award